MRNA Financial Statements & Analysis
Complete financial statements for MRNA including income statement, balance sheet, and cash flow statement. Analyze MRNA's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
38
Concerning
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
-53.3% ↓
Net Income
24.5% ↑
Gross Margin
72.3% ↑
Operating Margin
-99.2% ↓
Balance Sheet
Current Ratio
7.2% ↑
Debt to Equity
-23.6% ↑
Asset Turnover
-39.1% ↓
Cash Flow
Operating Cash Flow
3.7% ↑
Net Cash Flow
-245.7% ↓
Free Cash Flow
-6.0% ↓
Cash Flow to Debt
-60.3% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 6.85B | 3.20B | 53.3% | |
| Gross Profit | 2.15B | 1.74B | 19.5% | |
| Operating Income | -4239000000 | -3945000000 | 6.9% | |
| Net Income | -4714000000 | -3561000000 | 24.5% | |
| EPS | -12.34 | -9.27 | 24.9% | |
| EBITDA | -3283000000 | -3394000000 | 3.4% | |
| Gross Margin | 31.47% | 54.24% | 72.3% | |
| Operating Margin | -61.90% | -123.32% | 99.2% | |
| Net Income Margin | -68.84% | -111.32% | 61.7% | |
| R&D Expenses | 4.84B | 4.54B | 6.2% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 3.20B | 6.85B | 18.88B | 17.74B | 803.39M |
| Gross Profit | 1.74B | 2.15B | 13.46B | 15.12B | 764.21M |
| Operating Income | -3945000000 | -4239000000 | 9.42B | 13.30B | -763144000 |
| Net Income | -3561000000 | -4714000000 | 8.36B | 12.20B | -747064000 |
| EPS | -9.27 | -12.34 | 21.26 | 30.31 | -1.96 |
| EBITDA | -3394000000 | -3283000000 | 9.77B | 13.53B | -703376000 |
| Gross Margin | 54.24% | 31.47% | 71.31% | 85.24% | 95.12% |
| Operating Margin | -123.32% | -61.90% | 49.91% | 74.97% | -94.99% |
| Net Income Margin | -111.32% | -68.84% | 44.30% | 68.80% | -92.99% |
| R&D Expenses | 4.54B | 4.84B | 3.29B | 1.99B | 1.37B |